X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22615) 22615
Publication (1667) 1667
Book Review (228) 228
Book Chapter (207) 207
Conference Proceeding (36) 36
Dissertation (16) 16
Magazine Article (14) 14
Book / eBook (11) 11
Streaming Video (6) 6
Newsletter (5) 5
Data Set (4) 4
Government Document (4) 4
Newspaper Article (3) 3
Reference (3) 3
Presentation (2) 2
Web Resource (2) 2
Journal / eJournal (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18201) 18201
transplantation, autologous (11930) 11930
female (10459) 10459
male (10161) 10161
index medicus (8905) 8905
middle aged (8426) 8426
adult (8354) 8354
hematology (6993) 6993
transplantation (6935) 6935
oncology (5590) 5590
treatment outcome (4784) 4784
aged (4634) 4634
stem cells (3730) 3730
hematopoietic stem cell transplantation (3710) 3710
animals (3458) 3458
adolescent (3192) 3192
immunology (3185) 3185
chemotherapy (2912) 2912
combined modality therapy (2807) 2807
antineoplastic combined chemotherapy protocols - therapeutic use (2755) 2755
therapy (2597) 2597
surgery (2356) 2356
care and treatment (2314) 2314
retrospective studies (2229) 2229
bone marrow transplantation (2184) 2184
stem cell transplantation (2092) 2092
autologous transplantation (1996) 1996
cancer (1881) 1881
follow-up studies (1820) 1820
multiple myeloma - therapy (1758) 1758
child (1748) 1748
transplantation, homologous (1731) 1731
prognosis (1729) 1729
bone-marrow-transplantation (1727) 1727
hematopoietic stem cells (1662) 1662
hematopoietic stem cell transplantation - methods (1656) 1656
high-dose chemotherapy (1620) 1620
multiple myeloma (1585) 1585
disease-free survival (1584) 1584
time factors (1561) 1561
bone-marrow transplantation (1554) 1554
young adult (1519) 1519
health aspects (1470) 1470
medicine, research & experimental (1454) 1454
stem-cell transplantation (1383) 1383
research (1369) 1369
recurrence (1355) 1355
analysis (1335) 1335
survival (1331) 1331
medicine & public health (1308) 1308
bone marrow (1260) 1260
autologous stem cell transplantation (1248) 1248
colony-stimulating factor (1231) 1231
autografts (1224) 1224
survival analysis (1218) 1218
remission induction (1215) 1215
risk factors (1213) 1213
prospective studies (1188) 1188
orthopedics (1158) 1158
survival rate (1153) 1153
hematopoietic stem cell transplantation - adverse effects (1119) 1119
child, preschool (1110) 1110
cell biology (1093) 1093
non-hodgkins-lymphoma (1087) 1087
antineoplastic combined chemotherapy protocols - administration & dosage (1081) 1081
blood (1000) 1000
cells, cultured (998) 998
disease (979) 979
immunotherapy (956) 956
regeneration (945) 945
cyclophosphamide (919) 919
transplantation, autologous - methods (917) 917
lymphoma (916) 916
mice (916) 916
cyclophosphamide - administration & dosage (913) 913
progenitor cells (905) 905
high-dose therapy (890) 890
bone-marrow (859) 859
blood transfusion, autologous (853) 853
lymphoma, non-hodgkin - therapy (851) 851
neoplasms - therapy (847) 847
stem-cells (843) 843
antineoplastic agents - therapeutic use (826) 826
tissue engineering (814) 814
hematology, oncology and palliative medicine (813) 813
biotechnology & applied microbiology (807) 807
article (806) 806
antineoplastic combined chemotherapy protocols - adverse effects (801) 801
autologous chondrocyte implantation (794) 794
peripheral blood stem cell transplantation (788) 788
trial (787) 787
medicine, general & internal (779) 779
autologous (765) 765
repair (764) 764
cell & tissue engineering (756) 756
stem cell transplantation - methods (748) 748
patient outcomes (737) 737
transplantation conditioning - methods (735) 735
transplants & implants (734) 734
mesenchymal stem-cells (731) 731
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21469) 21469
German (363) 363
Japanese (323) 323
French (216) 216
Russian (202) 202
Chinese (174) 174
Spanish (90) 90
Polish (38) 38
Italian (32) 32
Hungarian (28) 28
Czech (22) 22
Danish (17) 17
Norwegian (16) 16
Korean (13) 13
Portuguese (13) 13
Dutch (11) 11
Turkish (11) 11
Serbian (7) 7
Croatian (6) 6
Finnish (5) 5
Swedish (4) 4
Slovak (3) 3
Ukrainian (3) 3
Hebrew (2) 2
Romanian (2) 2
Slovenian (2) 2
Bosnian (1) 1
Bulgarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BioImpacts, ISSN 2228-5660, 12/2018, Volume 8, Issue Suppl 1, pp. S1 - S129
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 36, pp. 4462 - 4469
Journal Article
Journal Article
Journal Article
Journal Article
Journal of clinical apheresis, ISSN 0733-2459, 1982
Journal
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 874 - 885
Summary Background Relapsed multiple myeloma has no standard treatment, and the role of autologous stem-cell transplantation (ASCT) has not been fully defined.... 
Hematology, Oncology and Palliative Medicine | MAINTENANCE | SUPERIORITY | BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE | IMPACT | METAANALYSIS | ONCOLOGY | CLINICAL-TRIALS | LENALIDOMIDE | SALVAGE THERAPY | INDUCTION | MARROW TRANSPLANTATION | Recurrence | Cyclophosphamide - administration & dosage | Peripheral Nervous System Diseases - chemically induced | Consolidation Chemotherapy - methods | Humans | Middle Aged | Pyrazines - administration & dosage | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Multiple Myeloma - therapy | Time Factors | Adult | Female | Boronic Acids - administration & dosage | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Bortezomib | Dexamethasone - administration & dosage | Proportional Hazards Models | Thrombocytopenia - chemically induced | Disease Progression | Induction Chemotherapy - adverse effects | Retreatment | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Aged | Multiple Myeloma - genetics | Stem Cell Transplantation - adverse effects | Care and treatment | Relapse | Multiple myeloma | Clinical trials | Transplantation | Diseases | Cyclophosphamide | Chemotherapy | Hospitals | Stem cells | Dosage and administration | Product development | Cancer
Journal Article
Gene, ISSN 0378-1119, 08/2013, Volume 525, Issue 2, pp. 174 - 181
Substantial progress has been made in the past decade in treating several primary immunodeficiency disorders (PIDs) with gene therapy. Current approaches are... 
WAS | CGD | PID | Gene therapy | HSCT | SCID | REPERTOIRE | SEVERE COMBINED IMMUNODEFICIENCY | STEM-CELLS | CHRONIC GRANULOMATOUS-DISEASE | CELL TRANSPLANTATION | NEUTROPHILS | LENTIVIRAL VECTORS | TRANSGENE EXPRESSION | GENETICS & HEREDITY | INSERTIONAL MUTAGENESIS | RECONSTITUTION | Immunologic Deficiency Syndromes - therapy | Agammaglobulinemia - therapy | Humans | Hematopoietic Stem Cell Transplantation | Severe Combined Immunodeficiency - therapy | X-Linked Combined Immunodeficiency Diseases - therapy | Clinical Trials as Topic | Granulomatous Disease, Chronic - therapy | Transplantation, Autologous - methods | Hematopoietic Stem Cells - immunology | Immunologic Deficiency Syndromes - genetics | Mutagenesis, Insertional | Adenosine Deaminase - deficiency | Transgenes | Genetic Therapy - methods | Health aspects | Genes | Hematopoietic stem cells | Index Medicus | HLA, human leukocyte antigen | UCOE, ubiquitous chromatin opening element | PEG, polyethylene glycol | DSB, double strand break | SFFV, spleen focus-forming virus | EF-1α, elongation factor 1α | MDS, myelodysplastic syndrome | Review | PGK, phosphoglycerokinase | HSCs, haematopoietic stem cells | VSV-G, vesicular stomatitis virus-G protein | RVs, retroviral vectors | GALV, gibbon ape leukaemia virus | LCR, locus control region | TALEN, transcription activator-like effector nucleases | CGD, chronic granulomatous disorder | GvHD, graft versus host disease | GSH, genomic safe harbour | T-ALL, T cell-acute lymphoblastic leukaemia | ROS, reactive oxygen species | ADA-SCID, adenosine deaminase deficiency-severe combined immunodeficiency | NADPH, nicotinamide adenine dinucleotide phosphate hydrogen | LTR, long terminal repeat | IFN, interferon | LVs, lentiviral vectors | SIN, self-inactivating | miR, microRNA | XLN, X-linked neutropenia | HSCT, haematopoietic stem cell transplant | SAE, serious adverse event | WAS, Wiskott–Aldrich syndrome | HR, homologous recombination | SCID-X1, X-linked severe combined immunodeficiency | IL, interleukin | WASp, Wiskott–Aldrich syndrome protein | PIDs, primary immunodeficiency disorders | ERT, enzyme replacement therapy | MN, meganucleases | XLT, X-linked thrombocytopenia | MLV, murine leukaemia virus | NK cells, natural killer cells | ZFN, zinc finger nuclease
Journal Article
Journal Article
Circulation Research, ISSN 0009-7330, 08/2011, Volume 109, Issue 4, pp. 428 - 436
RATIONALE:A growing number of patients with coronary disease have refractory angina. Preclinical and early-phase clinical data suggest that intramyocardial... 
stem cells | angiogenesis | endothelial progenitor cells (EPC) myocardial ischemia | myocardial regeneration | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | CELL TRANSPLANTATION | RANDOMIZED CONTROLLED-TRIAL | RESEARCH ISSUES | METASTATIC COLORECTAL-CANCER | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | UNIVERSAL DEFINITION | DOUBLE-BLIND | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | ARTERY-DISEASE | Antigens, CD34 - metabolism | Prospective Studies | Angina Pectoris - mortality | Angina Pectoris - physiopathology | United States | Humans | Middle Aged | Endothelial Cells - transplantation | Tomography, Emission-Computed, Single-Photon | Male | Transplantation, Autologous | Angina Pectoris - etiology | Blood Component Removal | Angina Pectoris - pathology | Microcirculation | Exercise Test | Time Factors | Hematopoietic Stem Cell Transplantation - adverse effects | Myocardial Ischemia - physiopathology | Female | Surveys and Questionnaires | Myocardial Ischemia - mortality | Hematopoietic Stem Cell Mobilization | Biomarkers - metabolism | Coronary Circulation | Double-Blind Method | Risk Assessment | Risk Factors | Myocardium - pathology | Treatment Outcome | Myocardial Ischemia - pathology | Endothelial Cells - immunology | Cardiovascular Agents - therapeutic use | Regeneration | Regression Analysis | Angina Pectoris - surgery | Myocardial Ischemia - complications | Exercise Tolerance | Least-Squares Analysis | Aged | Myocardial Ischemia - surgery | Neovascularization, Physiologic
Journal Article